3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Hepatocellular
16
Cholangiocarcinoma
8
Barrett Esophagus
6
Thyroid Neoplasms
5
Recurrence
5
Pancreatic Neoplasms
5
Liver Neoplasms
5
Neoplasm Metastasis
4
Lung Neoplasms
4
Breast Neoplasms
4
Thyroid Nodule
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Thyroid Diseases
2
Thyroid Cancer, Papillary
2
Prostatic Neoplasms
2
Pain
2
Neoplasms
2
Hyperaldosteronism
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Agnosia
2
Squamous Intraepithelial Lesions
1
Rectal Neoplasms
1
Papillary Thyroid Microcarcinoma
1
Pancreatic cancer, adult
1
Pancreatic Neuroendocrine Tumors, WHO Grade I-II
1
Neuroma
1
Neuralgia
1
Interventions
Exercise
3
Control Groups
2
pyrotinib
1
Yoga
1
Waiting Lists
1
Trastuzumab
1
Self-Help Groups
1
Radiofrequency Ablation
1
Radiation Dose Hypofractionation
1
Neoadjuvant Therapy
1
Mastectomy, Segmental
1
Mammaplasty
1
Educational Status
1
Diet
1
Culture Techniques
1
Caloric Restriction
1
Anesthesia, General
1
Anesthesia, Conduction
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Breast Cancer Female
×
Radiofrequency Ablation
×
Clear all
NCT04389216
2025-09-15
RFA
Hospital Universitari de Bellvitge
Phase NA
Completed
30 enrolled